Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07636252
Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
Sponsor: Sheba Medical Center
View on ClinicalTrials.gov
Summary
This observational study evaluates if ex-vivo lung cancer drug sensitivity testing results correlate with the driver mutations found by genetic sequencing and if it can predict treatment response.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2023-06-14
Completion Date
2030-01-01
Last Updated
2026-06-23
Healthy Volunteers
No
Interventions
OTHER
Non-Interventional Study
Non-Interventional Study, patients go through pleural drainage due to shortness of breath
Locations (1)
Sheba Medical Center
Ramat Gan, Israel, Israel